ghk cu injection safety GHK-Cu Peptide Injection: Clinical Considerations – PlexusDx ghk-cu injection safety human The

Conclusions The colonization of C

The recurring findings were that the substances are not well characterised, that human evidence of effectiveness is thin or absent for the proposed routes of administration, and that immunogenicity risk has not been assessed

Unfortunately, these peptides are not covered by insurance and are a cash pay item

Exercise: the strongest natural BDNF booster No intervention in the scientific literature matches the consistency and magnitude of exercise for increasing BDNF

Key Areas of Research: Endocrine: Somatotroph axis, signaling, cascades

Since everyone biology varies, trying both peptides at different times can help identify which works better for a specific person